Time elapsed between the hematologic manifestation and the thrombotic event or pregnancy morbidity. (A) Group of patients in whom the hematologic manifestation preceded clinical APS (median, 3 years; range, 0.5-10 years). (B) Group of patients in whom the hematologic manifestation followed clinical APS (median, 4.4 years; range, 0.1-32).